Drug Marketing

OxyContin Health Products Consumer Marketing Compounding Pharmacies Obesity Treatments Product Regulation Telehealth Services Ethical Practices Consumer Advocacy Litigation

6 ARTICLES

3w ago

Lilly Sues Six U.S. Sellers Over Black‑Market Retatrutide

The drugmaker asked platforms, payment firms and regulators to cut off the channels that let unapproved and potentially unsafe products reach consumers.

5 ARTICLES

4w ago

Eli Lilly Opens Limited Early Access to Experimental Obesity Drug Retatrutide

5 ARTICLES

5mo ago

Telangana Regulator Warns Against Unsupervised Semaglutide Use

9 ARTICLES

6mo ago

TrumpRx Debuts With 43 Discounted Brand Drugs as Analyses Flag Cheaper Generics and Limits

5 ARTICLES

11mo ago

Alameda County Confronts Fentanyl-Driven Overdoses With Expanded Care and Youth Prevention

9 ARTICLES

last yr.

Jury Finds Zantac Not Responsible for Illinois Woman's Colon Cancer

Drug Marketing

Lilly Sues Six U.S. Sellers Over Black‑Market Retatrutide

Eli Lilly Opens Limited Early Access to Experimental Obesity Drug Retatrutide

Telangana Regulator Warns Against Unsupervised Semaglutide Use

TrumpRx Debuts With 43 Discounted Brand Drugs as Analyses Flag Cheaper Generics and Limits

Alameda County Confronts Fentanyl-Driven Overdoses With Expanded Care and Youth Prevention

Eli Lilly Expands Legal Fight Against Compounded GLP-1 Drugs

Eli Lilly Sues Strive and Empower Over Unapproved Tirzepatide Products

Eli Lilly Sues Vendors for Selling Unauthorized Tirzepatide Products

Jury Finds Zantac Not Responsible for Illinois Woman's Colon Cancer